Bienvenue chez nous!
Logo Ex Libris

Novel Drug Combination for Treating Hypertension and Dyslipidemia

  • Couverture cartonnée
  • 132 Nombre de pages
"To Study Effectiveness of Novel Drug Combination Containing Atenolol and Atorvastatin for Simultaneously Treating Hypertension an... Lire la suite
CHF 69.00
Habituellement expédié sous 1 semaine.

Description

"To Study Effectiveness of Novel Drug Combination Containing Atenolol and Atorvastatin for Simultaneously Treating Hypertension and Dyslipidemia" Hypertension and dyslipidemia are two of the most commonly co-occurring cardiovascular risk factors. In a recent study utilizing data from various clinical studies, it was estimated that almost 15% of adults have both hypertension and dyslipidemia. It was also shown that more than 64% of patients with hypertension also have dyslipidemia; conversely, approximately 47% of patients with dyslipidemia have hypertension. These two risk factors together cause an increase in coronary heart disease-related events that is more than simply additive for anticipated event rates with each disease. This study was undertaken to find out the physical and pharmacological compatibility of atenolol and atorvastatin so that both drug can be incorporated in one doses form like tablet or capsule. Because of such study patient adherence to therapy will be increased and definitely lower the cost of treatment.

Détails sur le produit

Titre: Novel Drug Combination for Treating Hypertension and Dyslipidemia
Sous-titre: Atenolol and Atorvastatin
Auteur:
Code EAN: 9783330046603
ISBN: 978-3-330-04660-3
Format: Couverture cartonnée
Genre: Médecine
nombre de pages: 132
Poids: g
Taille: H220mm x B220mm x T150mm
Année: 2017